Cases

583 F.3d 766 (2009) ASTRAZENECA PHARMACEUTICALS LP and Astrazeneca UK Limited, Plaintiffs-Appellees, v. TEVA PHARMACEUTICALS USA, INC. and Teva Pharmaceutical Industries, Ltd., Defendants-Appellants, and Sandoz, Inc., Defendant-Appellant. Nos. 2008-1480, 2008-1481. United States Court of Appeals, Federal Circuit. September 25, 2009.

*18WOODALL, Justice. AstraZeneca LP and AstraZeneca Pharmaceuticals LP (hereinafter referred to jointly as “AstraZeneca”);1 SmithKline Beecham Corporation d/b/a GlaxoSmithK-line (“GSK”); and Novartis Pharmaceuticals Corporation (“Novartis”) appeal from judgments entered on jury verdicts in favor of the State of Alabama in actions alleging that

Opinion & Order BARBARA S. JONES, District Judge. *387TABLE OF CONTENTS INTRODUCTION. CO CO o I. The Parties. CO CO o II. The Patents-In-Suit. 03 05 CO A. Patent Ownership. CO CO III. The Pleadings. CO CO A. Complaint Against Mylan/Esteve.

Reyna, Circuit Judge. *1336 Alkem Laboratories Limited, Hikma Pharmaceuticals International Limited, and Hikma Pharmaceuticals USA Inc. appeal the judgment of the district court that

ORDER LISA GODBEY WOOD, CHIEF JUDGE This matter comes before the Court on six Motions to Dismiss filed by the several Defendant airlines: Delta Air Lines, Inc. (“Delta”) (dkt. no. 88)1; ABC Aerolíneas, S.A. de C.V. (“Interjet”) (dkt. no. 89); United Airlines, Inc. (“United”) (dkt. no. 93); Concesionaria Vuela Compañía de Aviación, S.A.P.I. de C.V. (‘Volaris”) (dkt. no. 97); A

IN THE SUPERIOR COURT OF THE STATE OF DELAWARE STATE OF DELAWARE, ex rel. KATHLEEN JENNINGS, Attorney General of the State of Delaware, Plaintiff, C.A. NO. Nl 8C-01-223 MMJ CCLD V. PURDUE PHARMA L.P.; PURDUE PHARMA INC.; THE PURDUE FREDERICK COMPANY; ENDO HEALTH SOLUTIONS INC.; ENDO PHARMACEUTICALS INC.; MCKESSON CORPORATION; CARDINAL HEALTH INC.; AMERISOURCEBERGEN CORPORATION; ANDA PHARMACEUTICALS, INC.; H.D. SMITH, LLC; CVS HEALTH CORPORATION; and WALGREENS BOOTS ALLIANCE, INC., `, \ /VV\

PER CURIAM. The defendant below, Sandoz, Inc. (“Sandoz”), appeals from a judgment entered on a jury verdict in favor of the plaintiff, the State of Alabama. The State alleged at trial that Sandoz, a manufacturer of generic pharmaceuticals, purposely reported inflated pricing information for generic drugs in third-party publications and that the State, using those published prices, overpaid certain reimbursements to providers o

OPINION Sue L. Robinson, Senior District Judge I. INTRODUCTION This consolidated case arises out of the filing of Abbreviated New Drug Applications (“ANDAs”) by defendants Sigmap-harm Laboratories, LLC (“Sigmapharm”); Breckenridge : Pharmaceutical, Inc. (“Breckenridge”); Hikma. Pharmaceuticals, LLC, Hikma Pharmaceuticals, PLC, and West-Ward Pharmaceutical Corporation (collectively, “Hi

661 F.Supp.2d 218 (2009) RxUSA WHOLESALE, INC., Plaintiff, v. ALCON LABORATORIES, INC. et al., Defendants. No. 06-CV-3447 (DRH)(AKT). United States District Court, E.D. New York. September 24, 2009. *221 The Law Firm of Michael Levine, P.C., by: Michael L. Levine, Esq., Scarsdale, NY, for the Plaintiff. Latham & Watkin

655 F.Supp.2d 1270 (2009) SOUTHEAST LABORERS HEALTH AND WELFARE FUND, On behalf of itself and all others similarly situated, Plaintiffs, v. BAYER CORPORATION, Bayer Healthcare Pharmaceutical, Inc., Bayer Healthcare, LLC, Bayer Healthcare, A.G., Defendants. This Order relates to Case No. 08-80873. Case No. 08-1928-MD. United States District Court, S.D. Florida. July 30, 2009

Opinion and Order BARBARA S. JONES, District Judge. TABLE OF CONTENTS INTRODUCTION ..............................................................303 I. The Parties .............................................................304 A. Teva ................................................................304 B.

United States Court of Appeals for the Federal Circuit 03-1269, -1286 EDWARD H. PHILLIPS, Plaintiff-Appellant, v. AWH CORPORATION, HOPEMAN BROTHERS, INC., and LOFTON CORPORATION, Defendants-Cross Appellants. Carl F. M

Opinion for the court filed by Circuit Judge BRYSON, in which Chief Judge MICHEL and Circuit Judges CLEVENGER, RADER, SCHALL, GAJARSA, LINN, DYK, and PROST join; and in which Circuit Judge LOURIE joins with respect to parts I, II, III, V, and VI; *1309and in which Circuit Judge PAULINE NEWMAN joins with respect to parts I, II, III, and V. Opinion concurring in part and dissenting in part filed b

(2008) In re: ZYPREXA PRODUCTS LIABILITY LITIGATION. In re: Eli Lilly and Company Securities Litigation. Nos. 04-MDL-1596, 07-CV-1310. United States District Court, E.D. New York. April 30, 2008. MEMORANDUM, ORDER & JUDGMENT JACK B. WEINSTEIN, Senior District Judge: Table of Contents I.

490 F.Supp.2d 381 (2007) In re OMEPRAZOLE PATENT LITIGATION. Astrazeneca AB, et al., Plaintiffs, v. Mylan Laboratories Inc., et al., Defendants. Astrazeneca AB, et al., Plaintiffs, v. Laboratorios Dr. Esteve, S.A., et al., Defendants. Astrazeneca AB, et al., Plaintiffs, v. Lek Pharmaceutical and Chemical Co., D.D., et al., Defendants. Astrazeneca AB, et al., Plaintiffs, v. Apotex Corp., et al., Defendants.<